| Targeted cancer therapy through antibody fragments-decorated nanomedicines A Alibakhshi, FA Kahaki, S Ahangarzadeh, H Yaghoobi, F Yarian, ... Journal of Controlled Release 268, 323-334, 2017 | 159 | 2017 |
| Antimicrobial peptides (AMPs): roles, functions and mechanism of action R Seyfi, FA Kahaki, T Ebrahimi, S Montazersaheb, S Eyvazi, ... International Journal of Peptide Research and Therapeutics 26, 1451-1463, 2020 | 157 | 2020 |
| High Overexpression and Purification of Optimized Bacterio-Opsin from Halobacterium Salinarum R1 in E. coli FA Kahaki, V Babaeipour, HR Memari, MR Mofid Applied biochemistry and biotechnology 174, 1558-1571, 2014 | 27 | 2014 |
| Recent advances on immune targeted therapy of colorectal cancer using bi-specific antibodies and therapeutic vaccines A Azadi, A Golchini, S Delazar, F Abarghooi Kahaki, SM Dehnavi, ... Biological Procedures Online 23, 1-13, 2021 | 22 | 2021 |
| Expression and production of recombinant scorpine as a potassium channel blocker protein in Escherichia coli R Seyfi, V Babaeipour, MR Mofid, FA Kahaki Biotechnology and applied biochemistry 66 (1), 119-129, 2019 | 19 | 2019 |
| Expression and purification of membrane proteins in different hosts F Abarghooi Kahaki, S Monzavi, H Bamehr, E Bandani, Z Payandeh, ... International Journal of Peptide Research and Therapeutics 26, 2077-2087, 2020 | 7 | 2020 |
| Designing a diagnostic kit for Oxalyl CoA Decarboxylase enzyme by ELISA method F Abarghooi-Kahaki, A Basiri, M Bandehpour, B Kazemi Immunology Letters 205, 78-83, 2019 | 2 | 2019 |
| Expression optimizing of recombinant Oxalyl-CoA decarboxylase in Escherichia coli FA Kahaki, SM Dehnavi Advanced Biomedical Research 11 (1), 110, 2022 | | 2022 |
| Enhanced production of human Epidermal Growth Factor (EGF) in Escherichia coli. MM Namvaran, V Babaeipour, H Vahidi, J Ranjbari, FA Kahaki, ... | | 2015 |
Amir Ali MokhtarzadehAssistant Professor of Pharmaceutical Biotechnology,Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
